LC3‐Associated Phagocytosis in Hepatitis C Virus–Induced Fibrosis
Microbiology and Immunology · 2026-06 · 70 (6) · 315-320
DOI: 10.1111/1348-0421.70058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology and Immunology, online erschienen am 29.04.2026. Verfasst von Nermine Magdi Riad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, Kasr AlAiny Faculty of Medicine, Cairo University, Giza, Egypt. Hauptthemen laut MEDLINE: Phagocytosis, Liver Cirrhosis, Hepacivirus, Microtubule-Associated Proteins. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
During LC3‐associated phagocytosis (LAP), a non‐canonical form of autophagy, LC3 is recruited to pathogen and apoptotic cells containing phagosomes, where the phagocytosed cargo is degraded. Given the importance of LAP in host defense and the role of phagocytic cells in liver inflammation and fibrosis, this study assessed LAP in peripheral blood neutrophils and monocytes from patients with variable degrees of liver fibrosis and cirrhosis secondary to viral hepatitis C infection. LAP was quantified by flow cytometry using labeled zymosan as a stimulus to engage LAP and LC3 antibodies to detect LC3 recruitment. LAP engagement was evaluated as the integrated mean fluorescence intensity of LC3 in zymosan‐positive cells. LAP was enhanced in patients with mild to moderate liver fibrosis (stages F1–F2) compared with patients with no fibrosis (F0) and severe fibrosis or cirrhosis (stages F3–F4). Furthermore, LAP in both neutrophils and monocytes correlated with the stage of fibrosis from F0 to F2, indicating that as the process of fibrosis progressed in the early stages, LAP activity increased. No differences in LAP were observed between treatment‐naïve and those who received direct acting antiviral therapy and achieved sustained virologic response (SVR), suggesting that the process of fibrosis had a more significant impact on LAP, rather than the presence or absence of HCV infection. In conclusion, LAP is enhanced in circulating phagocytes during early stages of HCV‐related fibrosis but declines in advanced disease, independent of treatment status and SVR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pathology Department, Kasr AlAiny Faculty of Medicine, Cairo University, Giza, Egypt.
- Department of Endemic Medicine, Kasr AlAiny Faculty of Medicine, Cairo University, Giza, Egypt.
ORCID-Profile: Hend H Tamim, Mariam Onsy F Hanna
Zitieren
APA
Riad, N. M., Masoud, Z. W., Gaber, Y., El Hawary, R., Yosry, A., Tamim, H. H., Zayed, N. A., & Hanna, M. O. F. (2026). LC3‐Associated Phagocytosis in Hepatitis C Virus–Induced Fibrosis. Microbiology and Immunology, 70(6), 315-320. https://doi.org/10.1111/1348-0421.70058
Vancouver
Riad NM, Masoud ZW, Gaber Y, El Hawary R, Yosry A, Tamim HH, et al. LC3‐Associated Phagocytosis in Hepatitis C Virus–Induced Fibrosis. Microbiology and Immunology. 2026;70(6):315-320. doi:10.1111/1348-0421.70058
BibTeX
@article{Riad2026,
author = {Riad, Nermine Magdi and Masoud, Zainab Wafik and Gaber, Yasmine and El Hawary, Rabab and Yosry, Ayman and Tamim, Hend H and Zayed, Naglaa Ali and Hanna, Mariam Onsy F},
title = {LC3‐Associated Phagocytosis in Hepatitis C Virus–Induced Fibrosis},
journal = {Microbiology and Immunology},
year = {2026},
volume = {70},
number = {6},
pages = {315--320},
doi = {10.1111/1348-0421.70058}
}
EUVIMED